A Response to: Letter to the Editor Regarding “Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder”

Dean M. Wingerchuk, Ina Zhang, Adrian Kielhorn, Minying Royston, Michael Levy, Kazuo Fujihara, Ichiro Nakashima, Imran Tanvir, Friedemann Paul, Sean J. Pittock

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)1445-1449
Number of pages5
JournalNeurology and Therapy
Issue number3
StatePublished - Sep 2022


  • Aquaporin-4 immunoglobulin G-positive
  • Bayesian network meta-analysis
  • Eculizumab
  • Inebilizumab
  • Matching-adjusted indirect comparison
  • Neuromyelitis optica spectrum disorder
  • Randomized controlled trial
  • Satralizumab

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this